HNP ϭ herniated nucleus pulposus; HZAP ϭ herpes zoster-associated pain; PLPS ϭ postlaminectomy pain syndrome. * P Ͻ 0.001.
BACKGROUND: Transforaminal epidural injection (TEI) is commonly used in the treatment of radicular pain. However, there have been many published cases of serious complications after a TEI, occurring most often in cervical levels. One of the presumptive reasons for this complication is inadvertent intravascular injection. We sought to identify the incidence of intravascular injections in cervical and lumbar spinal segments during TEI. METHODS: All patients with radicular symptoms or herpes zoster-associated pain underwent cervical and lumbar TEIs (LTEIs) prospectively by one of the authors. After an ideal needle position was confirmed by biplanar fluoroscopy, 3 mL of a mixture containing nonionic contrast and normal saline was continuously injected at the rate of 0.3-0.5 mL/s with real-time fluoroscopic visualization. RESULTS: One hundred eighty-two TEIs were performed. Fifty-six cases (30.8%) showed intravascular spreading patterns, 45 cases occurring during a cervical TEI (CTEI) and 11 during a LTEI. The incidences of simultaneous perineural and vascular injection in cervical and LTEIs were 52.1% and 9%, respectively, and pure vascular flow pattern rates in cervical and LTEIs were 11.3% and 0.9%, respectively. CONCLUSION: The incidence of vascular injection in CTEIs is significantly higher than in LTEIs, suggesting that CTEIs should be performed more cautiously. Furthermore, the vascular injection rate of CTEIs is much higher than that previously reported. This finding suggests the need for a proper volume of contrast injection (3 mL) to detect vascular flow, especially in simultaneous perineural and vascular injections. Epi dural injections with or without corticosteroid have been used worldwide for the management of acute or chronic pain since the first introduction of steroids into the epidural space in 1952. 1 Epidural injection may be classified as being interlaminar, caudal, or transforaminal, depending upon the approach taken to the epidural space. The transforaminal approach is target specific, using the smallest volume of injectate closer to the dorsal root ganglion and facilitating better ventral epidural flow to the involved nerve root complex, compared with other methods. 2, 3 However, there are many published reports of serious complications after transforaminal epidural injections (TEIs) occurring more frequently at the cervical level than others. 2,4 -9 The most serious complications caused by TEI include paraplegia or quadriplegia from spinal cord infarction and coma, death or disability from infarction in the distribution of the posterior cerebral circulation, including brainstem and/or cerebella infarction. Causes of these complications have been explained by vasospasm, direct vascular trauma, and an embolus made of particulate steroids, which are related to intravascular injections. 2,4 -9 The purpose of this study was to identify the incidence of intravascular injection in cervical and lumbar spinal segments during a TEI, using a mixture of contrast media and saline in the same volume of injectate as treatment drug with real-time fluoroscopic guidance.
METHODS
The study was approved by the IRB at Ajou University Hospital. From November 2007 to March 2008, 182 consecutive patients who were scheduled to undergo TEI were enrolled. The inclusion criteria of this study were patients with radicular pain caused by herniated nucleus pulposus, herpes zoster-associated pain, spinal stenosis, postlaminectomy syndrome, and other conditions, including complex regional pain syndrome, central pain, and sprain. Patients who had nonradicular pain, known allergies to contrast media, or coagulopathy were excluded. All patients were provided with an explanation of the purpose of this study, and an informed consent was obtained. All procedures were performed by one of the authors under fluoroscopic guidance with contrast enhancement.
Patients were prepared and draped in a sterile fashion on a fluoroscopic table. For cervical TEI (CTEI), we preferred patients to be in a lateral oblique position, and the fluoroscope (OEC ® series 9800, G.E., Farifield, CT) was adjusted to get the proper oblique view for showing the biggest neural foramen. The patients were placed in a lateral oblique position with the injected side of the body tilted about 30°anteriorly. To obtain the best oblique view of the cervical intervertebral foramen, a true lateral view was performed first, and then the fluoroscope was rotated to a 35°-45°anterior oblique position on the side to be injected, in which the pedicle was in the upper half of the height and anterior half of the width of the vertebral body, and the superior articular process was placed in the lower half of the posterior intervertebral foramen (Fig. 1A) . With an optimal oblique view, a needle (8 cm, 21 gauge, Neurotic Nerve Block Needle ® , Hakko, Japan) was inserted by targeting the posterior and upper one third of the superior articular process. Once a needle touched the superior articular process (Fig. 1B) , the needle was advanced 1-2 mm slightly anteriorly and medially. At this point, an anterior posterior (AP) view of the fluoroscopic image was needed to evaluate the depth of the needle. While frequently checking the AP view under live fluoroscopic visualization, the needle was slowly advanced until it reached the lateral portion of the pedicle from the AP view. The destination of the needle on the AP view was the point that was not beyond the midline of the articular pillar ( Fig. 1C ).
For the lumbar TEI (LTEI), the fluoroscope was adjusted to get a proper oblique view while the patient was in a prone position. To obtain the best oblique view of the lumbar intervertebral foramen, a true AP view was made first and the fluoroscope was rotated toward the side to be injected approximately 30°. A 21-G needle was advanced to the pars interarticularis and into the neural foramen. After the ideal needle position at all levels was confirmed by biplanar fluoroscopy, 1 min was allowed to pass to detect spontaneous bleeding through the needle hub. Subsequently, gentle aspiration from the needle was done, and 3 mL of a mixture (2 mL of 370 mgI/mL of nonionic contrast media, iopamidol [IOPAMIRO ® , Bracco s.p.a., Millano, Italy] and 1 mL of normal saline) was continuously injected at the rate of 0.3-0.5 mL/s under a real-time fluoroscopic visualization to detect any intravascular injection. After fluoroscopically confirming a nonvascular injection, 3 mL of 0.3% mepivacaine with 10 mg of triamcinolone was injected.
We defined contrast patterns as perineural, simultaneous perineural and peripheral vascular, simultaneous perineural, and central vascular and purely vascular flow (Fig. 2 ). Only perineural pattern was defined as contrast agent spread along the neural sheath without any flow disappearance ( Fig. 2A) . Simultaneous perineural and vascular pattern was defined as contrast agent spreading along the neural sheath with partial contrast flow disappearance in any direction (Figs. 2B and C). If vascular flow occurred along with perineural contrast spread, we identified the flow direction as going to the periphery (Fig. 2B ) or toward the midline of vertebral column (Fig. 2C ). Only vascular pattern was defined as contrast agent spreading out through the vascular channel first (Fig.  2D ), and then it was washed out completely and immediately after showing vascular uptake. Data were collected, including patient's age, gender, diagnosis, and duration of symptoms. We classified the patients into two age groups of younger than and older than 65 yr. Before performing the study, we hypothesized that the estimated probability of vascular injection in LTEI and CTEI was 10% and 30%, respectively, after reviewing related articles and our experience. Based on a Type 1 error level of 0.05, Type 2 error level of 0.2, and a two-sided test, we needed 59 patients for each treatment group. Seventy-one CTEI and 110 LTEI patients were consecutively allocated. All statistical analyses were performed with SPSS version 13 (SPSS, Chicago, IL). Student's t-test was used to calculate statistical differences in continuous variables, and 2 test and Fisher's exact test were used for comparing categorical variables. A logistic regression was performed to identify factors associated with the vascular injection.
RESULTS
This study included 182 TEIs performed in 71 cervical and 111 lumbar segments without any complications. The characteristics of study patients are presented in Table 1 . There was no significant difference in any characteristic between the cervical and lumbar patients. Approximately half of the patients suffered from a herniated nucleus pulposus and one quarter of them had herpes zoster-associated pain ( Table 1) .
Overall vascular injections, including simultaneous vascular and perineural injections and only vascular injections, were observed in 45 of the 71 CTEIs (63.4%) and 11 of the 111 LTEIs (9.9%). The total intravascular injection rate, including purely vascular and simultaneous perineural and vascular uptake, in the cervical segment was significantly higher (P Ͻ 0.001) compared with the lumbar injections. Fifty-two percentage of the cervical injections resulted in simultaneous perineural and vascular spread, whereas 9% of the lumbar injections showed a dual contrast spreading pattern (P Ͻ 0.001). The purely vascular injection rate in the cervical region was 11.3% (8/71) compared with 0.9% (1/111) in the lumbar region (P Ͻ 0.006). Eleven cases of 71 CTEIs (15%) showed a vascular flow pattern on AP view running to the vertebral column. However, there was a significantly different result in LTEI; there was one case of intravascular uptake (0.9%) running to the midline of the vertebral column (P Ͻ 0.001) ( Table 1) .
Tables 2 and 3 present the incidence of intravascular injections at each of the cervical and lumbar vertebral segments. The size of samples was too small in the individual vertebral levels to make statistically significant conclusions about the incidence of vascular injection at each level. Nevertheless, all C5 TEIs produced both vascular and neural patterns, and 75% of the vascular injections associated with C3 and C6 TEIs resulted in both vascular and neural patterns. A C8 TEI (33.3%) was less likely to result in vascular injections than other CTEIs. In L3 and L4 TEIs, no vascular injections occurred. Flashback of blood upon preinjection aspiration was not observed in 80% (45/56) of the intravascular uptake cases.
There was no statistically significant correlation between the observed contrast pattern and subject's age, gender, diagnosis, and pain site ( Table 4 ).
DISCUSSION
The overall incidence of vascular injections during CTEIs and LTEIs was 30.7%, with an incidence of 9.9% at lumbar levels and a much higher incidence of 63.4% at cervical levels. In the lumbar segments, our results are similar to those previously described. 10 -12 On the other hand, the incidence of vascular injections associated with CTEIs was much higher than the 19.4% reported by Furman et al., 13 which is the only other report of this kind. One possible reason for the discrepancy could be the volume of contrast solution. Furman et al. used 0.5-2 mL of nonionic contrast for detecting intravascular injection instead of a fixed volume of contrast agent. For the CTEI technique, the use of a small volume of contrast agent (0.5-1 mL) was recommended to visualize the intravascular injection under real-time fluoroscopic guidance, 14, 15 and Furman et al. did not mention the point at which they stopped contrast injection. Nevertheless, they might have stopped injecting a small volume of contrast agent once they confirmed the contrast flow to spread into the epidural space through the spinal nerve root or vascular fleet.
In this study, we adjusted contrast mixture volume, injection speed, and viscosity of pure contrast media to be similar to the real treatment solution. We used 3 mL of contrast mixture in the same volume as the local anesthetics with steroid for the treatment. The reason for using the mixture of contrast media and normal saline instead of pure contrast agent was to reduce its viscosity. In our experience, a small volume of contrast agent is not sufficient to detect the incidence of a TEI-associated intravascular injection, because we observed a simultaneous perineural and vascular flow pattern in some cases only after injecting more than 0.5 mL of contrast mixture. Even though the use of real-time fluoroscopy could detect the incidence of vascular injection more than twice than intermittent fluoroscopy, it could miss the spread of the contrast agent through the tiny vessels. 16 In some cases of a simultaneous perineural and vascular spreading, we could detect the vascular flow at the end of injecting the contrast mixture. Therefore, if most of the contrast spread to the perineural structure and little to the vessels, we would not be able to detect the vascular flow.
In this study, we used same sized needles and same rate of 0.3-0.5 mL/s contrast injection, and one of the authors, who has 12 yr of experience in interventional pain management, performed the study procedures. There are several factors that could influence the occurrence of intravascular injection during a TEI: age, spinal level of injection, practitioner's experience, injection technique, injection speed, needle size, etc. Sullivan et al. 12 reported that spinal level of injection and needle size did not have any relationship with the incidence of TEI-associated intravascular injections, which physicians with Ͻ2 yr of experience had a higher incidence of TEI-associated intravascular injection of TEIs than those with more than 2 yr of experience, and there was a strong trend toward an increase of incidence of intravascular uptake as a patient's age increased. 12 In this study, however, there was no significant difference in intravascular uptake rates between age groups, similar to the studies by Furman et al. 10, 13 Similar to previous results on CTEIs and LTEIs, in this study, we observed a significant difference in the intravascular injection rates between the cervical and lumbar spine. One of the reasons for the difference is that a different anatomy is involved in the arterial supply of the intervertebral foramina between the cervical and lumbar levels. In general, spinal arterial branches arise from the aorta and iliac vessels at the lumbar and thoracic levels. In the cervical spine, however, spinal arterial branches arise from the vertebral, ascending cervical, superior intercostals, and deep cervical arteries. 17 In the CTEIs, the technique used in this study appears to be proper, avoiding vertebral artery puncture by keeping the needletip placed immediately anterior to the portion of the superior articular process, where the posterior portion of the dorsal root ganglion is located. 14, 15 On the other hand, cervical radicular arteries arise from ascending cervical or deep cervical arteries, which are located in the posterior aspect of the intervertebral foramen. Huntoon 18 demonstrated that ascending and deep cervical arterial branches enter the external opening of the posterior intervertebral foramen near the classic target area for TEIs, and that those arteries could possibly be cannulated during the CTEI procedure because of their large size at the external foraminal openings. They concluded that there are variable anastomoses between the vertebral and cervical arteries, and that the posterior, caudal aspect of the foramen is the most vulnerable area, among the arteries supplying the spinal cord, to be punctured. According to Huntoon, 18 there is no safer area of the cervical intervertebral foramen to perform TEIs. In this study, two thirds of the CTEIs resulted in vascular flows, regardless of the sizes of the vessels, arteries, or veins. In humans, one or two of the cervical segmental medullary vessels may feed into the anterior spinal artery. 18 Among our vascular flows, we could not unravel exactly which vessels were critical for reinforcing the spinal cord. However, we could postulate that 15.5% of cases of CTEIs running to the midline of the vertebral column would be feeding the artery to the spinal cord because of the vascular direction. Among 15.5% of the vascular flow cases in CTEIs, flow patterns supplying the superficial area of the spine might be included because a fluoroscopic view shows only two-dimensional images. On the other hand, we could estimate that 26 cases (36.6%) of CTEIs and nine (8.1%) of the LTEIs showing the perineural and peripheral vascular pattern would be venous flows. The most serious concern about vascular injection in TEIs is that administration of drug into arteries feeding the spinal cord possibly leads to disastrous neurologic complications. An inadvertent venous injection may also result in deceasing the treatment efficacy and central nervous system toxicity. Most intravascular uptake patterns from our data were postulated venous flows, which would be free from catastrophic complications.
This study has some limitations. First, we did not differentiate between venous or arterial flow. Although intraarterial injection is manifested by a more rapid clearance of injected contrast agent than venous flow and vascular flow direction to the spinal cord, an exact differentiation might be difficult during contrast injection in TEIs. Using AP view, we evaluated whether vascular flow direction was running to the midline of the vertebral body or toward the periphery. Although vascular flow toward the midline implies arterial flow, this is not certain. Fluoroscopy cannot show threedimensional radiographic images. Recently, threedimensional digital subtraction angiography clearly provided clinicians with better information about the relationships between the feeding arteries and draining veins in the intervetral foramen and helped to discriminate between intramedullary or perimedullary flow. 19 However, it has started to be used in diagnosis and performance of the endovascular procedures in spinal vascular malformation but has not yet been used in pain practice.
Second, we could not reach statistically significant differences in the intravascular incidences according to the individual spinal segment because of the small sample size. When we conducted statistics, however, our present data showed that TEIs in cervical segment C8 had the smallest number of intravascular injections.
Third, we did not analyze the number of times that the needle was repositioned to avoid a vascular injection. In some cases of CTEIs, an intravascular injection could not be avoided despite repeated needle repositioning, as Furman et al. 13 have demonstrated. However, we were able to obtain a nonvascular pattern with just one needle repositioning in almost all lumbar vascular injection cases. We have not yet found the definite needle position in CTEIs to avoid a vascular injection. More research and a future study with larger sample size should be performed to analyze the incidence of intravascular injection according to the individual spinal segment and to find the best needle position to avoid a vascular injection.
In conclusion, the overall incidence of vascular injection in CTEIs is significantly higher than in LTEIs and also much higher than previously reported. Majority of the intravascular uptake in TEIs are postulated to be venous; however, 15.5% of the CTEIs should be considered to be possible dangerous arterial injection. This finding might be explained by the fact that an appropriate volume of contrast injection (3 mL) needs to be used to detect vascular flow, especially in simultaneous perineural and vascular injections. Our present observation also suggests that CTEIs should be performed based on careful detection of vascular flow patterns by an experienced practitioner, and further research is needed to find a technique to reduce intravascular injection.
